Study: Prostate Cancer Cells Hate Broccoli, Too.
A new study shows that a nutrient found in cruciferous vegetables like broccoli virtually stops the cell progression of several common types of prostate cancer. This nutrient is already available as a supplement and many men and women are using it right now for detoxification and hormonal support. Find out more about it in today’s AllStarHealth blog.
DIM or diindolemethane, is a nutrient found in cruciferous vegetables like broccoli and cabbage, well-researched foods already known to be very healthy and nutritious. DIM isn’t a necessary nutrient like vitamins or minerals, but it has some interesting properties that have induced supplement brands to offer DIM in supplement form. Researchers also continue to explore the functions and benefits of DIM, with very promising results such as these.
In this study, several common types of prostate cancer cells were cultured, then exposed to DIM, after which effects on cell regulation and progression were measured several ways. DIM was shown to stop the cell progression of prostate cancer cells, which should be a finding of enormous significance given how common, costly and difficult to treat prostate cancer is, and how safe and affordable DIM is. Whether or not that turns out to be the case hinges on several unlikely contingencies.
Interest in DIM has centers around the way it enhances the liver’s ability to clear a wide range of toxins including excess steroid hormones, particularly estrogen. Since increasing estrogen levels or estrogen activity leads to many health problems for aging men (prostate) and women (breast, reproductive health), DIM is one of the most-commonly used nutrients to promote hormone balance by minimizing excess estrogen activity. DIM is one of the few legitimate ‘anti-estrogen’ nutrients available in this respect. Other nutrients men and women use include calcium d-glucarate and supplemental zinc.
Needless to say, no one should regard DIM as a preventative agent or treatment for prostate cancer at this point in time; this was an in-vitro study. But neither should it be dismissed out of hand, either, it may have a beneficial role to play and is something that men with or at risk for prostate cancer should at least discuss with their physician.